New prospects for the treatment of COPD patients
An estimated 251 million people around the world are living with COPD.1
Recent evidence indicates that treatment with home non-invasive ventilation (NIV) has benefits for COPD patients with chronic stable hypercapnia.
ResMed is working with respiratory physicians, healthcare systems and insurers to increase awareness of home NIV therapy, and has developed connected home NIV solutions that are suitable for the treatment of COPD.
The COPD toolkit offers clinical and practical information on the management of COPD with home NIV, as well as exclusive workshops, interviews and videos.
I would like to receive further information about ResMed’s products and services by email.
Download the toolkit